We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Deepaneeta Sarmah

Deepaneeta Sarmah MPharm

PhD Research Scholar, Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER) - Ahmedabad, Gandhinagar, Gujarat, India

Ms. Deepaneeta Sarmah is currently a doctoral candidate in National Institute of Pharmaceutical Education and Research (NIPER), Ahmedabad, Gandhinagar, India. She is pursuing her doctoral degree in Pharmacology and Toxicology, where she is working to decipher the mechanism of mitochondrial protection in ischemic stroke following mesenchymal stem cell transplantation in rodents. Ms. Sarmah has over 25 peer reviewed publications primarily on stroke, stem cells and mitochondria.

Previously, Ms. Sarmah obtained her master’s degree in Pharmacology from Indian Institute of Technology (IIT-BHU), Varanasi, India.